Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 88, Topic 2
In Progress

Diagnostic Assessment and Classification of Acid–Base Disorders

Lesson Progress
0% Complete
Diagnostic Assessment and Classification of Acid–Base Disorders

Diagnostic Assessment and Classification of Acid–Base Disorders

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Objective

Apply a systematic approach to interpret arterial blood gas (ABG) values, calculate anion gap and delta ratio, recognize compensatory limits, and use classification tools to stratify severity and guide initial management.

1. Clinical Manifestations and Initial Evaluation

Early recognition of neurologic, cardiovascular, and respiratory signs drives timely arterial blood gas (ABG) sampling and acid–base assessment.

Neurologic

  • Acidemia: Manifests as a spectrum from confusion to lethargy, and ultimately to stupor or coma.
  • Alkalemia: Can cause paresthesias, tetany (due to decreased ionized calcium), and hyperreflexia.

Cardiovascular

  • Acidemia: Leads to decreased myocardial contractility, hypotension, and hyperkalemia, which increases the risk for arrhythmias.
  • Alkalemia: Associated with hypokalemia and hypomagnesemia, which can prolong the QT interval and precipitate torsades de pointes.

Respiratory

  • Metabolic acidosis: Characterized by Kussmaul respirations (deep, rapid breathing) as a compensatory mechanism.
  • Respiratory acidosis: Results from hypoventilation, causing dyspnea.
  • Respiratory alkalosis: Presents with tachypnea and may cause lightheadedness.

Initial Workup

A comprehensive initial evaluation includes an ABG with a basic metabolic panel (Na⁺, Cl⁻, HCO₃⁻, albumin) and a thorough history focusing on volume status, drug exposures, and underlying chronic diseases.

Pearl Icon A lightbulb icon, indicating a clinical pearl. Key Pearls Accordion Toggle Icon
  • Neuromuscular signs of alkalemia can be masked by sedation or neuromuscular blockers in critically ill patients.
  • In lactic acidosis, a patient’s mental status may correlate better with the lactate level than with the pH alone.

2. Arterial Blood Gas Interpretation

A stepwise ABG approach—assessing pH first, then determining the primary respiratory (PaCO₂) versus metabolic (HCO₃⁻) disturbance—is crucial. This framework is based on the Henderson–Hasselbalch equation: pH = pKa + log([HCO₃⁻] / (0.03 × PaCO₂)).

Normal Laboratory Ranges

  • pH: 7.35–7.45
  • PaCO₂: 35–45 mm Hg
  • HCO₃⁻: 22–26 mEq/L
ABG Interpretation Flowchart A flowchart showing the systematic approach to interpreting an arterial blood gas. It starts with assessing the pH, then branches to acidemia or alkalemia, and finally identifies the primary disorder based on PaCO2 and HCO3 levels. 1. Assess pH Acidemia (pH < 7.35) Alkalemia (pH > 7.45) ↓ HCO₃⁻ ↑ PaCO₂ Metabolic Acidosis Respiratory Acidosis ↑ HCO₃⁻ ↓ PaCO₂ Metabolic Alkalosis Respiratory Alkalosis
Figure 1: Stepwise Approach to ABG Interpretation. This diagnostic algorithm guides the clinician from the initial pH value to the primary acid-base disorder by examining the directional change in bicarbonate (HCO₃⁻) and carbon dioxide (PaCO₂).
Pearl Icon A lightbulb icon, indicating a clinical pearl. Key Pearls Accordion Toggle Icon
  • A normal pH with abnormal PaCO₂ and HCO₃⁻ is a strong indicator of a mixed acid-base disturbance.
  • Always verify sample integrity. Delayed analysis or storage at room temperature can falsely elevate PaCO₂ due to ongoing cellular metabolism.

3. Anion Gap and Delta-Ratio Analysis

The anion gap (AG) is used to identify the presence of unmeasured anions, while the delta ratio helps to unmask mixed metabolic acidoses.

Anion Gap (AG) Calculation

  • Formula: AG = [Na⁺] – ([Cl⁻] + [HCO₃⁻])
  • Normal Range: 8–12 mEq/L
  • Albumin Correction: Since albumin is the primary unmeasured anion, the AG must be corrected for hypoalbuminemia. A common formula is: Corrected AG = Measured AG + 2.5 × (4.0 – measured albumin [g/dL]).

Delta Ratio

The delta ratio assesses the relationship between the increase in the anion gap (ΔAG) and the decrease in bicarbonate (ΔHCO₃⁻).

  • Calculation: Δ Ratio = (AGmeasured – 12) / (24 – HCO₃⁻measured)
  • Interpretation:
    • 1 to 2: Suggests a pure high-AG metabolic acidosis (HAGMA).
    • <1: Suggests a mixed HAGMA and normal-AG metabolic acidosis (NAGMA), as HCO₃⁻ has decreased more than the AG has increased.
    • >2: Suggests a concurrent metabolic alkalosis, as HCO₃⁻ is higher than expected for the degree of AG elevation.
Pearl Icon A lightbulb icon, indicating a clinical pearl. Key Pearls Accordion Toggle Icon
  • Always correct the anion gap for hypoalbuminemia in critically ill patients to avoid missing a HAGMA.
  • Reference ranges for the anion gap can vary by laboratory. Confirm your institution’s normal values.

4. Compensatory Mechanisms and Expected Limits

Calculating the expected physiologic compensation is a critical step to distinguish simple acid-base disorders from more complex mixed disturbances. A mixed disorder is suspected whenever the actual measured values fall outside the predicted ranges.

Formulas for Expected Physiologic Compensation
Primary Disorder Expected Compensation Formula Notes / Context
Metabolic Acidosis Expected PaCO₂ = (1.5 × HCO₃⁻) + 8 ± 2 Known as Winter’s formula. Compensation is rapid (respiratory).
Metabolic Alkalosis Expected PaCO₂ ≈ 40 + (0.7 × [HCO₃⁻ – 24]) Compensation (hypoventilation) is limited; PaCO₂ rarely exceeds 55 mm Hg.
Respiratory Acidosis Acute: ↑HCO₃⁻ by 1 per 10 ↑PaCO₂
Chronic: ↑HCO₃⁻ by 3.5 per 10 ↑PaCO₂
Distinction between acute (<24h) and chronic (>72h) is key. Renal compensation is slow.
Respiratory Alkalosis Acute: ↓HCO₃⁻ by 2 per 10 ↓PaCO₂
Chronic: ↓HCO₃⁻ by 5 per 10 ↓PaCO₂
Chronic compensation reflects sustained renal excretion of bicarbonate.
Pearl Icon A lightbulb icon, indicating a clinical pearl. Key Pearls Accordion Toggle Icon
  • Always perform manual compensation calculations. ABG analyzers report values but do not flag mixed disorders.
  • Compensation formulas become less reliable at extreme pH values (e.g., pH < 7.10 or > 7.60).

5. Classification Systems and Severity Scores

Algorithms and severity metrics, such as base excess and the anion gap, help differentiate simple versus mixed disorders and inform the urgency of intervention.

Simple vs. Mixed Disorders

  • Simple Disorder: Consists of one primary disturbance with the appropriate physiologic compensation.
  • Mixed Disorder: Defined by the presence of more than one primary disorder. Compensation rules are violated.

Severity Thresholds and Metrics

  • Base Excess (BE): A BE less than –5 mEq/L indicates significant metabolic acidosis, while a BE greater than +5 mEq/L indicates significant metabolic alkalosis.
  • pH and Bicarbonate: A pH ≤7.20 or HCO₃⁻ ≤12 mEq/L is considered severe metabolic acidosis and warrants urgent attention.
  • Anion Gap: An AG >16 mEq/L is an independent predictor of higher mortality in critically ill patients.

Risk Stratification

Clinical risk is best assessed by combining pH, base excess, anion gap, and evidence of end-organ dysfunction (e.g., acute kidney injury). These scores guide escalation of care, such as consideration for bicarbonate therapy or early renal replacement therapy (RRT).

Pearl Icon A lightbulb icon, indicating a clinical pearl. Key Pearls Accordion Toggle Icon
  • Severe acidemia (pH ≤7.20) warrants rapid multidisciplinary evaluation involving critical care and nephrology.
  • Mixed disorders, such as a high anion gap metabolic acidosis combined with respiratory acidosis (hypoventilation), carry the highest risk and require simultaneous management of both ventilation and metabolic derangements.

References

  1. Barletta JF, Muir J, Brown J, Dzierba A. A systematic approach to understanding acid–base disorders in the critically ill. Ann Pharmacother. 2024;58(1):65-75.
  2. Kraut JA, Madias NE. Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol. 2007;2(1):162-174.
  3. Wrenn K. The delta (Δ) gap: An approach to mixed acid-base disorders. Ann Emerg Med. 1990;19(11):1310-1313.
  4. Lewis JL 3rd. Acid-Base Disorders. Merck Manual Professional Version. Updated March 12, 2025.
  5. Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomized controlled trial. Lancet. 2018;392(10141):31-40.
  6. Achanti A, Sood MM, Waikar SS. Acid–Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023;18(1):102-112.
  7. Dickerson RN. Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support. In: ACCP/SCCM Critical Care Pharmacy Preparatory Review. 2016.